Patterns and Predictors of Chemotherapy Use for Resected Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Patterns and Predictors of Chemotherapy Use for Resected Non-Small Cell Lung Cancer

Published:2016-02 Issue:2 Volume:101 Page:533-540
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Rajaram Ravi,Paruch Jennifer L.,Mohanty Sanjay,Holl Jane L.,Bilimoria Karl Y.,Ko Clifford Y.,Winchester David P.,Patel Jyoti D.,DeCamp Malcolm M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference30 articles.

1. Cancer Facts & Figures 2014: American Cancer Society. Available from: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014/index. Accessed Oct 1, 2014.

2. Le Chevalier T for the IALT Investigators. Results of the Randomized International Adjuvant Lung Cancer Trial (IALT): cisplatin-based chemotherapy (CT) versus no CT in 1867 patients with resected non–small-cell lung cancer. Presented at: 39th Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, May 31–June 3, 2003.

3. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer;Winton;N Engl J Med,2005

4. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial;Douillard;Lancet Oncol,2006

5. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non–small-cell lung cancer (NSCLC): report of Cancer and Leukemia Group B (CALGB) Protocol 9633;Strauss;J Clin Oncol,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Early-Stage Non-Small-Cell Lung Cancer;Current Oncology;2024-01-12

2. Impact of travel distance on receipt of indicated adjuvant therapy in resected non–small cell lung cancer;The Journal of Thoracic and Cardiovascular Surgery;2023-09

3. Adjuvant chemotherapy for completely resected IIA–IIIA non-small cell lung cancer: compliance to guidelines, safety and efficacy in real-life practice;Translational Lung Cancer Research;2022-12

4. Real-world treatment patterns in resectable (stages I–III) non-small-cell lung cancer: a systematic literature review;Future Oncology;2022-04

5. Use of adjuvant chemotherapy in resected non-small cell lung cancer in real-life practice: a systematic review of literature;Translational Lung Cancer Research;2021-12